Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT06141356
Eligibility Criteria:
Inclusion Criteria:
* Male or Female
* Age ≥ 40 years
* Healthy participants or patients with probable Alzheimer's disease or with dementia due to other causes
Exclusion Criteria:
* Has allergy to \[18F\]Florbetazine or any of its excipients ;
* Has hypersensitivity to \[11C\]PIB or any of its excipients ;
* Incapable of providing written informed consent or lacking a legally authorized representative (LAR) to provide informed consent ;
* Unwilling or unable to undergo PET scans tracer injections ;
* Unwilling or unable to undergo MRI;
* Any condition that, in the Investigator's opinion, could increase the risk to the participant, limit the participant's ability to tolerate the research procedures, or interfere with the collection/analysis of the data (e.g., renal or liver failure, advanced cancer);
* Women who are currently pregnant or breastfeeding;
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
90 Years
Study:
NCT06141356
Study Brief:
Protocol Section:
NCT06141356